When competitive intelligence is predictive rather than reactive, biopharma companies can grab the edge

In the dynamic global biopharma landscape, competitive intelligence (CI) is as indispensable as ever.

Read more >

Positive outlook for CDMOs at CPhI North America, but companies need to be ready for challenges

CPhI North America, running concurrently with InformEx, is a new addition to the global series of CPhI events.

Read more >

DCAT Week ’17 session looks at emerging pharma market trends

The health of emerging pharmaceutical companies can be assessed, in part, by financing and partnership activity with larger companies, Richard Harrison, Chief Scientific Officer at Clarivate Analytics, told a DCAT Week ’17 audience in a session titled “Emerging Pharma: Market Overview, Project Management and CMC Readiness.”

Read more >

Advancing evidence-based indication prioritization to navigate disease segmentation landscape

Innovation in genomic technologies over the past two decades has ushered in an explosion of new drug targets for drug discovery.

Read more >

Latin American market presents attractive opportunities in innovation and generics, but adaptability is key

The combined populations of the three most populous countries in Latin America – Brazil, Mexico, and Colombia – account for more than 350 million people. Pharmaceutical companies have long sought access to the growing market in Latin America and many have faced difficulties in doing so.

Read more >